Cargando…

B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome

BACKGROUND: Wiskott-Aldrich syndrome (WAS) is a severe X-linked immunodeficiency characterized by microthrombocytopenia, eczema, recurrent infections, and susceptibility to autoimmunity and lymphomas. Hematopoietic stem cell transplantation is the treatment of choice; however, administration of WAS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castiello, Maria Carmina, Scaramuzza, Samantha, Pala, Francesca, Ferrua, Francesca, Uva, Paolo, Brigida, Immacolata, Sereni, Lucia, van der Burg, Mirjam, Ottaviano, Giorgio, Albert, Michael H., Grazia Roncarolo, Maria, Naldini, Luigi, Aiuti, Alessandro, Villa, Anna, Bosticardo, Marita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mosby 2015
Materias:	Immune Deficiencies, Infection, and Systemic Immune Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559137/ https://www.ncbi.nlm.nih.gov/pubmed/25792466 http://dx.doi.org/10.1016/j.jaci.2015.01.035

Ejemplares similares

Autoimmunity in Wiskott–Aldrich Syndrome: An Unsolved Enigma
por: Catucci, Marco, et al.
Publicado: (2012)

Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott-Aldrich syndrome
por: Catucci, Marco, et al.
Publicado: (2011)

Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency
por: Lang, Philipp A., et al.
Publicado: (2013)

Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome
por: Sereni, Lucia, et al.
Publicado: (2019)

Wiskott–Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans()
por: Castiello, Maria Carmina, et al.
Publicado: (2014)

Preclinical Safety and Efficacy of Human CD34(+) Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome
por: Scaramuzza, Samantha, et al.
Publicado: (2013)

A novel genomic inversion in Wiskott-Aldrich–associated autoinflammation
por: Brigida, Immacolata, et al.
Publicado: (2016)

In Vivo Chronic Stimulation Unveils Autoreactive Potential of Wiskott–Aldrich Syndrome Protein-Deficient B Cells
por: Castiello, Maria Carmina, et al.
Publicado: (2017)

The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function
por: Locci, Michela, et al.
Publicado: (2009)

Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study
por: Ferrua, Francesca, et al.
Publicado: (2019)

Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature
por: Lucchese, Alessandra, et al.
Publicado: (2022)

Lymphocyte subsets in healthy Malawians: Implications for immunologic assessment of HIV infection in Africa
por: Mandala, Wilson L., et al.
Publicado: (2010)

Pattern recognition receptor-mediated cytokine response in infants across 4 continents(⋆)()
por: Smolen, Kinga K., et al.
Publicado: (2014)

Effects of maternal geohelminth infections on allergy in early childhood
por: Cooper, Philip J., et al.
Publicado: (2016)

An inherited immunoglobulin class-switch recombination deficiency associated with a defect in the INO80 chromatin remodeling complex
por: Kracker, Sven, et al.
Publicado: (2015)

Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding
por: Cetica, Valentina, et al.
Publicado: (2015)

Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry
por: Cetica, Valentina, et al.
Publicado: (2016)

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study
por: Coulter, Tanya I., et al.
Publicado: (2017)

Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells
por: Chen, Hannah H., et al.
Publicado: (2017)

Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency()
por: Hassan, Amel, et al.
Publicado: (2014)

Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin
por: Stier, Matthew T., et al.
Publicado: (2016)

A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation
por: Consiglieri, Giulia, et al.
Publicado: (2021)

Unraveling the Repertoire in Wiskott–Aldrich Syndrome
por: Petersen, Sven H., et al.
Publicado: (2014)

Wiskott-Aldrich syndrome protein–mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells
por: Prete, Francesca, et al.
Publicado: (2013)

Development of Central Nervous System Autoimmunity Is Impaired in the Absence of Wiskott-Aldrich Syndrome Protein
por: Bosticardo, Marita, et al.
Publicado: (2014)

Hypoxia-inducible lentiviral gene expression in engineered human macrophages
por: Chinn, Harrison K, et al.
Publicado: (2022)

Síndrome de Wiskott - Aldrich /
por: Tello Gabriel, Adriana

Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
por: Huckaby, Justin T, et al.
Publicado: (2021)

Safe and Effective Gene Therapy for Murine Wiskott-Aldrich Syndrome Using an Insulated Lentiviral Vector
por: Singh, Swati, et al.
Publicado: (2016)

Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering
por: Michels, Kathryn R, et al.
Publicado: (2023)

Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources
por: Schmidts, Andrea, et al.
Publicado: (2020)

Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy
por: Wielgosz, Matthew M, et al.
Publicado: (2015)

Autoimmunity in Wiskott–Aldrich Syndrome: Updated Perspectives
por: Sudhakar, Murugan, et al.
Publicado: (2021)

Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism
por: Serafini, Barbara, et al.
Publicado: (2019)

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome
por: Magnani, A., et al.
Publicado: (2022)

Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing
por: Marongiu, Laura, et al.
Publicado: (2021)

Corneal ulceration and episcleritis associated with Wiskott–Aldrich syndrome
por: Zagelbaum, Bruce M., et al.
Publicado: (2016)

Wiskott-Aldrich Syndrome: New Perspectives in Pathogenesis and Management
por: Standen, G. R.
Publicado: (1988)

Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19
por: Xiang, Jingyu, et al.
Publicado: (2022)

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome
por: Magnani, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7uojg3a2j55t5vo1t1sq8n252l